MCF7 Faslodex/FR Resistant Cell Line

Product Name	MCF7 Faslodex/FR Resistant Cell Line
Cat.No	RG-501
Size	1*10^6 cells/vial
Description	MCF7/FR Resistant Cell Line was developed by stepwise increased concentrations of Faslodex. Cells were continuously maintained in Faslodex, with treatments beginning at the initial IC50 of the respective parent cell lines.
Tissue	Mammary gland, breast; derived from metastatic site: pleural effusion
Species	Human
Disease	Breast adenocarcinoma
Parental Cell Line	MCF7
Biosafety Level	BSL 1. Runtogen determines the biosafety level of a material based on our risk assessment as guided by the current edition of Biosafety in Microbiological and Biomedical Laboratories (BMBL), U.S. Department of Health and Human Services.
Resistance	Faslodex
Morphology	Epithelial-like, Adherent
Culture Method	MEM+10%FBS+ 1%Non Essential Amino Acids (NEAA) + 1mM Sodium Pyruvate (NaP)+ +100nM Faslodex
Shipping	Cryopreserved cells are shipped with dry ice
Storage	Upon arrival, Check all containers for leakage or breakage. Remove the frozen cells from the dry ice packaging and immediately place the cells at a temperature below -130°C, preferably in liquid nitrogen vapor, until ready for use.
Warranty	Our Cell Line is warranted for 30 days from the date of shipment, provided that the customer has stored and handled the product according to the information included on the product datasheet, website, and COA.
Disclaimers	This cell line is intended for laboratory research use only. It is not intended for any human or animal therapeutic use, any animal or human consumption, or any diagnostic use. Any proposed commercial use is prohibited without a license from Runtogen.

MCF7 Faslodex/FR Resistant Cell Line

Online Inquiry

Online Inquiry